Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.

MLA

Shlay, Judith C., et al. “Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 38, no. 2, Feb. 2005, pp. 147–55. EBSCOhost, https://doi.org/10.1097/01.qai.0000143599.64234.15.

APA

Shlay, J. C., Visnegarwala, F., Bartsch, G., Wang, J., Peng, G., El-Sadr, W. M., Gibert, C., Kotler, D., Grunfeld, C., & Raghavan, S. (2005). Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine. Journal of Acquired Immune Deficiency Syndromes (1999), 38(2), 147–155. https://doi.org/10.1097/01.qai.0000143599.64234.15

Chicago

Shlay, Judith C, Fehmida Visnegarwala, Glenn Bartsch, Jack Wang, Grace Peng, Wafaa M El-Sadr, Cynthia Gibert, Donald Kotler, Carl Grunfeld, and Subhasree Raghavan. 2005. “Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine.” Journal of Acquired Immune Deficiency Syndromes (1999) 38 (2): 147–55. doi:10.1097/01.qai.0000143599.64234.15.